STOCK TITAN

TORM plc capital increase in connection with exercise of Restricted Share Units as part of TORM's incentive program

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Negative)
Tags

TORM plc (NASDAQ: TRMD A) increased share capital by 43,697 A-shares following exercise of Restricted Share Units on March 31, 2026. 10,634 shares were subscribed at DKK 131.80 and 33,063 at DKK 148.70. Post-issue share capital is USD 1,021,233.39 across 102,123,339 A-shares.

New shares are ordinary, carry dividend and voting rights from issuance, and are expected to list on Nasdaq Copenhagen as soon as possible.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Key Figures

New A-shares issued: 43,697 A-shares Nominal value issued: USD 436.97 New shares at DKK 131.80: 10,634 shares +5 more
8 metrics
New A-shares issued 43,697 A-shares Capital increase from RSU exercise
Nominal value issued USD 436.97 Nominal value of newly issued A-shares
New shares at DKK 131.80 10,634 shares Subscribed for in cash at DKK 131.80 per A-share
New shares at DKK 148.70 33,063 shares Subscribed for in cash at DKK 148.70 per A-share
Post-issue share capital USD 1,021,233.39 Total TORM share capital after RSU-related increase
Total A-shares outstanding 102,123,339 A-shares TORM A-shares after capital increase
Nominal per share USD 0.01 Nominal value of each TORM A-share
Voting rights 1 vote per A-share Each A-share carries one vote

Market Reality Check

Price: $112.03 Vol: Volume 1,039,209 vs 20-da...
low vol
$112.03 Last Close
Volume Volume 1,039,209 vs 20-day avg 2,302,269 (relative volume 0.45), indicating lighter-than-usual trading. low
Technical Shares trade below the 200-day MA, with price at 112.03 vs MA(200) 129.82.

Peers on Argus

The stock was up 1.61% while key peers showed mixed, mostly modest moves (e.g., ...

The stock was up 1.61% while key peers showed mixed, mostly modest moves (e.g., IQV +0.30%, MTD +0.47%, IDXX -0.69%, LH -1.13%), pointing to stock-specific drivers rather than a broad sector move.

Historical Context

5 past events · Latest: Mar 26 (Positive)
Pattern 5 events
Date Event Sentiment Move Catalyst
Mar 26 FDA companion approval Positive +0.4% FDA approval for PD-L1 IHC 22C3 pharmDx in GEJ carcinoma.
Mar 24 RSU capital increase Neutral +1.9% TORM increased share capital via RSU exercise at DKK 148.70.
Mar 23 CEO appointment Positive +1.9% Crawford & Company named W. Bruce Swain Jr. permanent CEO.
Mar 19 Oncology showcase Positive +0.2% Agilent highlighted precision oncology and digital pathology advances at USCAP.
Mar 17 Insider share sale Negative +0.8% TORM CEO sold 223,555 shares on Nasdaq Copenhagen at DKK 163.46.
Pattern Detected

Recent news—ranging from FDA approval to corporate and capital actions—has generally seen modest positive price reactions, with one insider-sale event showing a divergence.

Recent Company History

Over the past weeks, the company’s news flow has included an FDA approval for PD-L1 IHC 22C3 pharmDx on Mar 26, 2026, multiple director compensation-related equity grants, and several TORM-related capital and insider-transaction disclosures. Most items, including the $6.95 billion revenue backdrop and companion diagnostic expansion, were followed by small positive moves, while a sizable CEO share sale at DKK 163.46 saw a positive reaction, marking a divergence.

Market Pulse Summary

This announcement details a limited capital increase of 43,697 A-shares from RSU exercises, bringing...
Analysis

This announcement details a limited capital increase of 43,697 A-shares from RSU exercises, bringing TORM’s share capital to USD 1,021,233.39 across 102,123,339 A-shares with a nominal value of USD 0.01. The move reflects routine incentive-program activity without pre-emption rights. In context of prior insider transactions and earlier RSU exercises, investors may watch the frequency and scale of such issuances when assessing longer-term dilution and governance considerations.

Key Terms

restricted share units, pre-emption rights, negotiable instruments, forward-looking statements
4 terms
restricted share units financial
"as a result of the exercise of a corresponding number of Restricted Share Units"
Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.
pre-emption rights financial
"carried out without any pre-emption rights for existing shareholders or others"
A shareholder’s right to be offered new shares before they are sold to outsiders, allowing existing owners to buy enough to keep their ownership percentage. Think of it like being offered the first slice of a pie so your share doesn’t shrink; it matters to investors because it protects voting power and economic value from being diluted when a company issues more stock, and it can affect how easy or costly fundraising is.
negotiable instruments financial
"the new shares (i) are ordinary shares without any special rights and are negotiable instruments"
Negotiable instruments are written promises or orders to pay a specific sum of money that can be transferred from one person to another—examples include checks, promissory notes, and bills of exchange—so the current holder has the legal right to collect payment. They matter to investors because they act like tradable cash or IOUs, influencing a company’s liquidity and short-term credit risk; holding or issuing them affects how quickly a business can access cash and how safe its short-term finances appear.
forward-looking statements regulatory
"Matters discussed in this release may constitute forward-looking statements."
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

AI-generated analysis. Not financial advice.

HELLERUP, Denmark, March 31, 2026 /PRNewswire/ -- TORM plc (NASDAQ: TRMD) (NASDAQ: TRMD A) has increased its share capital by 43,697 A-shares (corresponding to a nominal value of USD 436.97) as a result of the exercise of a corresponding number of Restricted Share Units ("RSUs"). A total of 10,634 new shares are subscribed for in cash at DKK 131.80 per A-share, and 33,063 new shares are subscribed for in cash at DKK 148.70.

Transfer restrictions may apply in certain jurisdictions outside Denmark, including applicable US securities laws. The capital increase is carried out without any pre-emption rights for existing shareholders or others.

The new shares (i) are ordinary shares without any special rights and are negotiable instruments, (ii) give the right to dividends and other rights in relation to TORM as of the date of issuance and (iii) are expected to be admitted to trading and official listing on Nasdaq Copenhagen as soon as possible.

After the capital increase, TORM's share capital totals to USD 1,021,233.39 divided into 102,123,339 A-shares with a nominal value of USD 0.01 each. Each A-share carries one vote.

Contact
Mikael Bo Larsen, Head of Investor Relations
Tel.: +45 5143 8002

About TORM

TORM is one of the world's leading carriers of refined oil products. TORM operates a fleet of product tanker vessels with a strong commitment to safety. environmental responsibility and customer service. TORM was founded in 1889 and conducts business worldwide. TORM's shares are listed on Nasdaq in Copenhagen and on Nasdaq in New York (ticker: TRMD A and TRMD. ISIN: GB00BZ3CNK81). For further information, please visit www.torm.com.

Safe Harbor Statement as to the Future

Matters discussed in this release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements reflect our current views with respect to future events and financial performance and may include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are statements other than statements of historical facts. The Company desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. Words such as, but not limited to, "expects," "anticipates," "intends," "plans," "believes," "estimates," "targets," "projects," "forecasts," "potential," "continue," "possible," "likely," "may," "could," "should" and similar expressions or phrases may identify forward-looking statements.

The forward-looking statements in this release are based upon various assumptions, many of which are, in turn, based upon further assumptions, including without limitation, management's examination of historical operating trends, data contained in our records and other data available from third parties. Although the Company believes that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies that are difficult or impossible to predict and are beyond our control, the Company cannot guarantee that it will achieve or accomplish these expectations, beliefs, or projections.

Important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include, but are not limited to, our future operating or financial results; changes in governmental rules and regulations or actions taken by regulatory authorities; inflationary pressure and central bank policies intended to combat overall inflation and rising interest rates and foreign exchange rates; general domestic and international political conditions or events, including "trade wars" and the war between Russia and Ukraine, the developments in the Middle East, including the war in Israel and the Gaza Strip, and the conflict regarding the Houthis' attacks in the Red Sea; international sanctions against Russian oil and oil products; changes in economic and competitive conditions affecting our business, including market fluctuations in charter rates and charterers' abilities to perform under existing time charters; changes in the supply and demand for vessels comparable to ours and the number of newbuildings under construction; the highly cyclical nature of the industry that we operate in; the loss of a large customer or significant business relationship; changes in worldwide oil production and consumption and storage; risks associated with any future vessel construction; our expectations regarding the availability of vessel acquisitions and our ability to complete acquisition transactions planned; availability of skilled crew members other employees and the related labor costs; work stoppages or other labor disruptions by our employees or the employees of other companies in related industries;  effects of new products and new technology in our industry;  new environmental regulations and restrictions; the impact of an interruption in or failure of our information technology and communications systems, including the impact of cyber-attacks, upon our ability to operate; potential conflicts of interest involving members of our Board of Directors and Senior Management; the failure of counterparties to fully perform their contracts with us; changes in credit risk with respect to our counterparties on contracts; adequacy of insurance coverage; our ability to obtain indemnities from customers; changes in laws, treaties or regulations; our incorporation under the laws of England and Wales and the different rights to relief that may be available compared to other countries, including the United States; government requisition of our vessels during a period of war or emergency; the arrest of our vessels by maritime claimants; any further changes in U.S. trade policy that could trigger retaliatory actions by the affected countries; the impact of the U.S. presidential and congressional election results affecting the economy, future government laws and regulations and trade policy matters, such as the imposition of tariffs and other import restrictions; potential disruption of shipping routes due to accidents, climate-related incidents, adverse weather and natural disasters, environmental factors, political events, public health threats, acts by terrorists or acts of piracy on ocean-going vessels; damage to storage and receiving facilities; potential liability from future litigation and potential costs due to environmental damage and vessel collisions; and the length and number of off-hire periods and dependence on third-party managers.

In the light of these risks and uncertainties, undue reliance should not be placed on forward-looking statements contained in this release because they are statements about events that are not certain to occur as described or at all. These forward-looking statements are not guarantees of our future performance, and actual results and future developments may vary materially from those projected in the forward-looking statements.

Except to the extent required by applicable law or regulation, the Company undertakes no obligation to release publicly any revisions or updates to these forward-looking statements to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events. Please see TORM's filings with the U.S. Securities and Exchange Commission for a more complete discussion of certain of these and other risks and uncertainties. The information set forth herein speaks only as of the date hereof, and the Company disclaims any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this communication.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/torm-plc/r/torm-plc-capital-increase-in-connection-with-exercise-of-restricted-share-units-as-part-of-torm-s-in,c4328020

The following files are available for download:

https://mb.cision.com/Main/21247/4328020/4012151.pdf

10-2026 - TORM plc capital increase in connection with RSU exercise as part of TORM’s incentive program

 

Cision View original content:https://www.prnewswire.com/news-releases/torm-plc-capital-increase-in-connection-with-exercise-of-restricted-share-units-as-part-of-torms-incentive-program-302729662.html

SOURCE Torm PLC

FAQ

How many A-shares did TORM (TRMD A) issue on March 31, 2026?

TORM issued 43,697 A-shares on March 31, 2026 as a result of RSU exercises. According to the company, 10,634 were subscribed at DKK 131.80 and 33,063 at DKK 148.70, increasing outstanding A-shares to 102,123,339.

Were pre-emption rights offered to TORM (TRMD A) shareholders for the March 2026 issuance?

No; the capital increase was carried out without pre-emption rights for existing shareholders or others. According to the company, shares were issued in connection with RSU exercises under its incentive program.

Will the newly issued TORM (TRMD A) shares be tradable and where will they list?

Yes; the new shares are ordinary negotiable instruments and are expected to be admitted to trading and official listing on Nasdaq Copenhagen as soon as possible, according to the company.

Do the new TORM (TRMD A) shares carry dividends and voting rights from issuance?

Yes; the newly issued A-shares give the right to dividends and other shareholder rights from the date of issuance. According to the company, each A-share carries one vote and standard dividend entitlements.
Agilent Technologies Inc

NYSE:A

View A Stock Overview

A Rankings

A Latest News

A Latest SEC Filings

A Stock Data

31.15B
282.02M
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States
SANTA CLARA